Derisi et al., “Use of a cDNA microarray to analyse gene expression patterns in human cancer”, Nature Genetics, vol. 14, pp. 457-460, Dec. 1996.* |
Galang et al., “Oncogenic Neu/ErbB-2 Increases Ets, AP-1, and NF-kB-dependent Gene Expression, and Inhibiting Ets Activation Blocks Neu-mediated Cellular Transformation”, The Journal of Biological Chemistry, vol. 271 (14), pp. 7992-7998, Apr. 6, 1996.* |
Honkoop et al. “Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer” British Journal of Cancer (1998) 77 (4), 621-626. |
Tsitsiloni et al. “Expression of α-thymosins in human tissues in normal and abnormal growth” Proc. Natl. Acad. Sci. USA vol. 90 pp. 9504-9507 Oct. 1993. |
Elizabeth M. Jarvis et al. “Loss of Nuclear BRCA1 Expression in Breast Cancer is Associated with a Highly Proliferative Tumor Phenotype” Cancer Genet Cytogenet 101:109-115 (1998). |
Alvaro N.A. Monteiro et al. “Evidence for a transcriptional activation function of BRCA1 C-terminal region” Proc. Natl. Acad. Sci. USA, vol. 95, pp. 13595-13599 Nov. 1996. |
Yoshio Miki et al. “A Strong Candidate for the Breast and Ovarian Cancer Suceptibility Gene BRCA1” Science, vol. 266, Oct. 7, 1994 pp. 66-71. |
Mark S. Chapman et al., Nature, vol. 382, Aug. 22, 1996 “Transcriptional activation by BRCA1” pp. 678-679. |
Ralph Scully et al. “Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells” Cell, vol. 88, 265-275 Jan. 24, 1997. |